Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 2Uveal Melanoma 1Recurrence 1Plasmablastic Lymphoma 1Oligodendroglioma 1Neoplasms 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Glioblastoma 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

lifileucel 1fludarabine phosphate 1fludarabine 1Nivolumab 1Iodized Oil 1Ethiodized Oil 1Cyclophosphamide 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Carmustine × 30 days × Clear all
NCT04728633 2026-05-06

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Thomas Jefferson University

Phase 2 Active not recruiting
28 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡